1332 related articles for article (PubMed ID: 17200597)
41. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
Humphreys K; Moos R
Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
[TBL] [Abstract][Full Text] [Related]
42. Coverage for mental health treatment: do the gaps still persist?
Zuvekas SH; Meyerhoefer CD
J Ment Health Policy Econ; 2006 Sep; 9(3):155-63. PubMed ID: 17031020
[TBL] [Abstract][Full Text] [Related]
43. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
44. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
45. Estimation of mental health care cost units for patients with schizophrenia.
Saldivia Bórquez S; Torres González F; Cabasés Hita JM;
Actas Esp Psiquiatr; 2005; 33(5):280-5. PubMed ID: 16155809
[TBL] [Abstract][Full Text] [Related]
46. The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia.
Busch AB; Frank RG; Lehman AF
Arch Gen Psychiatry; 2004 May; 61(5):442-8. PubMed ID: 15123488
[TBL] [Abstract][Full Text] [Related]
47. [The analysis of the cost structures of the treatment of schizophrenia by means of standardized assessment instruments].
Kilian R; Roick C; Matschinger H; Bernert S; Mory C; Angermeyer MC
Psychiatr Prax; 2001 Oct; 28 Suppl 2():S102-8. PubMed ID: 11605132
[TBL] [Abstract][Full Text] [Related]
48. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan.
Croen LA; Najjar DV; Ray GT; Lotspeich L; Bernal P
Pediatrics; 2006 Oct; 118(4):e1203-11. PubMed ID: 17015508
[TBL] [Abstract][Full Text] [Related]
49. How mental health providers spend their time: a survey of 10 Veterans Health Administration mental health services.
Sullivan G; Jinnett KJ; Mukherjee S; Henderson KL
J Ment Health Policy Econ; 2003 Jun; 6(2):89-97. PubMed ID: 14578541
[TBL] [Abstract][Full Text] [Related]
50. Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?
Becker T; Kilian R
Acta Psychiatr Scand Suppl; 2006; (429):9-16. PubMed ID: 16445476
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
52. Activity based costing of probation with and without substance abuse treatment: a case study.
Alemi F; Taxman F; Doyon V; Thanner M; Baghi H
J Ment Health Policy Econ; 2004 Jun; 7(2):51-7. PubMed ID: 15208465
[TBL] [Abstract][Full Text] [Related]
53. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
Krentz HB; Auld MC; Gill MJ;
CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
[TBL] [Abstract][Full Text] [Related]
54. Service organisation, service use and costs of community mental health care.
Schneider J; Wooff D; Carpenter J; Brandon T; McNiven F
J Ment Health Policy Econ; 2002 Jun; 5(2):79-87. PubMed ID: 12529563
[TBL] [Abstract][Full Text] [Related]
55. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care.
Shelledy DC; Legrand TS; Gardner DD; Peters JI
J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130
[TBL] [Abstract][Full Text] [Related]
56. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS
Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267
[TBL] [Abstract][Full Text] [Related]
57. Effects of antipsychotic medication on psychiatric service utilization and cost.
Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
[TBL] [Abstract][Full Text] [Related]
58. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.
Floyd K; Skeva J; Nyirenda T; Gausi F; Salaniponi F
Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S29-37. PubMed ID: 12971652
[TBL] [Abstract][Full Text] [Related]
59. [Patient characteristics, length of treatment and costs in a model institution of community mental health care].
Dielentheis TF; Priebe S
Psychiatr Prax; 2002 May; 29(4):186-93. PubMed ID: 12021991
[TBL] [Abstract][Full Text] [Related]
60. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective.
Nicholl D; Akhras KS; Diels J; Schadrack J
Curr Med Res Opin; 2010 Apr; 26(4):943-55. PubMed ID: 20163295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
